Real-time enrollment status for this small-cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:57 PM UTC
| NCT Number | NCT07218146 |
| Recruiting Status | Recruiting |
| Condition | Small-cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 480 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Zai Lab (Shanghai) Co., Ltd. |
| Last Updated on CT.gov | September 14, 2026 (4 weeks ago) |
As of October 12, 2026: Clinical trial NCT07218146 is currently recruiting participants. This phase3 study for small-cell lung cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by Zai Lab (Shanghai) Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07218146 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07218146 was last updated 4 weeks ago (September 14, 2026). HelloStudys verifies this status automatically.